No effects on morphological progress have been observed in embryo-fetal enhancement studies with oral administration of methylphenidate to pregnant rats and rabbits in the course of organogenesis at doses as much as 10 and fifteen times, respectively, the maximum suggested human dose (MRHD) of sixty mg/working day provided to adolescents on the mg/